Navigation Links
HIRC Research Alert: New Study Identifies Best Pharmaceutical Company Account Managers and Program Offerings
Date:5/13/2010

Health Industries Research Companies has released its spring 2010 report assessing best pharmaceutical value-added programs and account managers among key managed care influencers.

Health Industries Research Companies (HIRC) Best Programs & Best People Service is an ongoing market research project that provides strategic and tactical information to assist pharmaceutical manufacturers in assessing value-added programs and account management strategies.

Best Manufacturer-supported Programs:
Managed care panelists most frequently nominate manufacturer-supported disease management, trend reports, patient education, appropriate drug utilization, and patient compliance as the best manufacturer-supported programs. HIRC’s Director of Best Programs & Best People research, Ms. Dee Dee Frye, notes that the “frequency of disease management and patient education mentions appear to be on the decline, while nominations for appropriate drug utilization and product performance guarantees are steadily increasing.”

The Program Profiles chapter of HIRC’s Best Programs Best People Service provides extensive profiles of 18 program areas. Each profile includes analyses of customer and manufacturer benefit, descriptions of the services provided, panelists’ interest, criteria for successful programs, and activities of the “best” manufacturers providing support in the program area.

Best Account Managers:
“As account managers face increasing barriers to access with managed care customers, HIRC research provides competitive benchmarking information and examines critical skills needed to build and maintain client relationships,” explains Dee Dee Frye. In spring 2010 HIRC queried leading managed care decision-makers to find out which pharmaceutical account executives are best meeting the needs of their managed care clients. GlaxoSmithKline more than doubled the number of best account manager nominations it received from HIRC panelists in 2010 compared to 2009, and currently secures for 10% of all nominations. The leading manufacturers in each category are noted below:

Best Large Manufacturers: GlaxoSmithKline, AstraZeneca, and Merck
Best Medium Manufacturers: Novo Nordisk, Forest, and Boehringer Ingleheim
Best Small Manufacturers: Amylin, Allergan, and Gilead

The Account Manager Performance chapter of HIRC’s Best Programs Best People Service provides insight into how these account managers differentiate themselves from their peers and overall attributes of successful account managers.

Research Methodology & Report Availability:
In January and February 2010, HIRC asked 124 HMO pharmacy and medical director, Medicare PDP executive, and pharmacy benefit manager panelists to assess their current experience with, and future interest in, pharmaceutical company-supported programs. Additionally panelists were asked to nominate the best account manager that called on them from a large, medium, and small manufacturer. In-depth follow-up interviews were conducted with 57 panelists.

The current reports on best manufacturer-supported programs (Chapter IV) and best pharmaceutical account managers (Chapter VI) are now available to pharmaceutical firm subscribers at hirc.com.

HEALTH INDUSTRIES RESEARCH COMPANIES (HIRC) is an independent, nonpartisan organization that conducts strategic market research on trends in health care, pharmaceutical, and managed care businesses. HIRC’s benchmark studies focus on the marketing needs of pharmaceutical companies by providing research critical to the development of successful customer-focused marketing strategies.

###

Read the full story at http://www.prweb.com/releases/2010/05/prweb3991104.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related medicine news :

1. Researchers demonstrate that safe cigarettes are as hazardous as tobacco
2. Level of frailty predicts surgical outcomes in older patients, Johns Hopkins researchers find
3. DCA research on brain cancer
4. The International Meeting for Autism Research (IMFAR)
5. OUHSC receives $100,000 Grand Challenges Explorations grant for innovative global health research
6. Cost Savings from Mobile Health Monitoring to Reach $1.9 billion to $5.8 Billion Globally by 2014 says Juniper Research
7. Trans-Atlantic agreement a boost to neuroscience research
8. Researchers discover new way to rescue treatment sensitivity of breast cancer cells
9. Georgetown Research Center Helps Reporters Decipher Health Reform Law & Impact on State Residents
10. Mild-mannered metabolic helper rushes to fight invading viruses, researchers report
11. Mayo-led research team develop agents that keep insulin working longer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... Ky. (PRWEB) , ... October 13, 2017 , ... The ... MPH to become its next President and Chief Executive Officer, succeeding Dr. James C. ... CEO Elect beginning July 1, 2018 until Dr. Puffer’s retirement at the end of ...
(Date:10/13/2017)... ... , ... Lori R. Somekh, founder of the Law Office of Somekh ... law and special needs planning attorneys. “Membership in ElderCounsel helps our office remain up ... network with elder law attorneys nationwide,” said Somekh. , ElderCounsel was ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading ... to advocate for action towards gender equality at their inaugural Summit in New York ... globe, and reached a social audience of over 3 million. To watch the Mobilize ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader ... been awarded a contract by the Center for Medicare and Medicaid Services (CMS). ... the enterprise use of Agile methodologies in a consistent and high value manner ...
(Date:10/12/2017)... Francisco, CA (PRWEB) , ... October 12, 2017 ... ... Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent ... apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, Inc. ... response letter from the U.S. Food and Drug Administration ... of sirukumab for the treatment of moderately to severely ... additional clinical data are needed to further evaluate the ... severely active RA. ...
(Date:9/19/2017)... -- HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy ... team developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D ...
(Date:9/18/2017)... Sept. 18, 2017 EpiVax, Inc. ... bioinformatics and immune engineering, today announced a ... A (H7N9) vaccine. ... seasonal influenza and presents a challenge for ... exposure to be effective. Using state-of-the-art bioinformatics and ...
Breaking Medicine Technology: